Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

11,274 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Glucose intolerance and diabetes as risk factors for cognitive impairment in people at high cardiovascular risk: results from the ONTARGET/TRANSCEND research programme.
Cukierman-Yaffe T, Gerstein HC, Anderson C, Zhao F, Sleight P, Hilbrich L, Jackson SH, Yusuf S, Teo K; ONTARGET/TRANSCEND Investigators. Cukierman-Yaffe T, et al. Among authors: zhao f. Diabetes Res Clin Pract. 2009 Mar;83(3):387-93. doi: 10.1016/j.diabres.2008.12.005. Epub 2009 Jan 20. Diabetes Res Clin Pract. 2009. PMID: 19157618
Sexual function, satisfaction, and association of erectile dysfunction with cardiovascular disease and risk factors in cardiovascular high-risk patients: substudy of the ONgoing Telmisartan Alone and in Combination with Ramipril Global Endpoint Trial/Telmisartan Randomized AssessmeNT Study in ACE-INtolerant Subjects with Cardiovascular Disease (ONTARGET/TRANSCEND).
Böhm M, Baumhäkel M, Probstfield JL, Schmieder R, Yusuf S, Zhao F, Koon T; ONTARGET/TRANSCEND ED-Investigators. Böhm M, et al. Among authors: zhao f. Am Heart J. 2007 Jul;154(1):94-101. doi: 10.1016/j.ahj.2007.03.024. Am Heart J. 2007. PMID: 17584560 Clinical Trial.
Early and late effects of clopidogrel in patients with acute coronary syndromes.
Yusuf S, Mehta SR, Zhao F, Gersh BJ, Commerford PJ, Blumenthal M, Budaj A, Wittlinger T, Fox KA; Clopidogrel in Unstable angina to prevent Recurrent Events Trial Investigators. Yusuf S, et al. Among authors: zhao f. Circulation. 2003 Feb 25;107(7):966-72. doi: 10.1161/01.cir.0000051362.96946.15. Circulation. 2003. PMID: 12600908 Clinical Trial.
The cost-effectiveness of the use of clopidogrel in acute coronary syndromes in five countries based upon the CURE study.
Lamy A, Jönsson B, Weintraub WS, Zhao F, Chrolavicius S, Bakhai A, Culler S, Gafni A, Lindgren P, Mahoney E, Yusuf S; CURE Economic Group. Lamy A, et al. Among authors: zhao f. Eur J Cardiovasc Prev Rehabil. 2004 Dec;11(6):460-5. doi: 10.1097/01.hjr.0000152239.28456.36. Eur J Cardiovasc Prev Rehabil. 2004. PMID: 15580055 Clinical Trial.
Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study.
Mehta SR, Yusuf S, Peters RJ, Bertrand ME, Lewis BS, Natarajan MK, Malmberg K, Rupprecht H, Zhao F, Chrolavicius S, Copland I, Fox KA; Clopidogrel in Unstable angina to prevent Recurrent Events trial (CURE) Investigators. Mehta SR, et al. Among authors: zhao f. Lancet. 2001 Aug 18;358(9281):527-33. doi: 10.1016/s0140-6736(01)05701-4. Lancet. 2001. PMID: 11520521 Clinical Trial.
Benefits and risks of the combination of clopidogrel and aspirin in patients undergoing surgical revascularization for non-ST-elevation acute coronary syndrome: the Clopidogrel in Unstable angina to prevent Recurrent ischemic Events (CURE) Trial.
Fox KA, Mehta SR, Peters R, Zhao F, Lakkis N, Gersh BJ, Yusuf S; Clopidogrel in Unstable angina to prevent Recurrent ischemic Events Trial. Fox KA, et al. Among authors: zhao f. Circulation. 2004 Sep 7;110(10):1202-8. doi: 10.1161/01.CIR.0000140675.85342.1B. Epub 2004 Aug 16. Circulation. 2004. PMID: 15313956 Clinical Trial.
11,274 results
You have reached the last available page of results. Please see the User Guide for more information.